About FDA
Number of contacts with the Pediatric Review Committee (PeRC), the review divisions, and other FDA colleagues to provide Pediatric Investigation Plan (PIP) information to inform internal discussions
Dictionary: A “contact” refers to written or oral communication between OPT and FDA colleagues (e.g. PeRC, review divisions in CDER or CBER, the Pediatric and Maternal Health Staff (PMHS) on matters relating to pediatric issues. E-mail is an example of written communication and a teleconference, as oral communication.
Information is current as of December 31, 2012.
Fiscal Year - 2013
| Time | Target | Number of Contacts |
|---|---|---|
| Oct 2012 | N/A | 14 |
| Nov 2012 | N/A | 4 |
| Dec 2012 | N/A | 3 |
| Jan 2013 | N/A | TBD |
| Feb 2013 | N/A | TBD |
| Mar 2013 | N/A | TBD |
| Apr 2013 | N/A | TBD |
| May 2013 | N/A | TBD |
| Jun 2013 | N/A | TBD |
| Jul 2013 | N/A | TBD |
| Aug 2013 | N/A | TBD |
| Sep 2013 | N/A | TBD |
FY 2013 YTD: 21
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
